Previa medical

Statut de l'investissement :


Nom du fondateur :

Quentin François, CEO & Co-founder and Barthélémy ARRIBE, CTO & Co-founder

Date d'investissement :


Résumé du projet

Previa Medical, a deeptech start-up specialized in the development of predictive medicine.

Previa has developed SEPSI-SCORE©, an artificial intelligence solution specializing in the early detection of sepsis, which has been certified as a medical device in 2021.
The platform alerts health professionals up to 48 hours before the first sepsis symptoms. The solution is integrated into the hospital’s business software and analyzes data from patients’ medical records in real time. It allows health professionals to accurately identify risks, start the treatment protocol as early as possible and thus increase patient survival.

L'apport de M2Care

A renseigner

Follow us
Contact us

A question? A project?
Our experts answer you